Back to results
US 8,772,344 B2Granted
Pharmaceutical composition for inhibiting osteoclast growth
AssigneeNational Defense Medical Center
InventorsDeh-Ming Chang, Hsu-Shan Huang
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition for inhibiting osteoclast growth is disclosed in the present invention. The pharmaceutical composition includes a compound represented by a formula (I), and a pharmaceutically acceptable salt and carrier: wherein R1, R2, R3, R4 can be one selected from a group consisting of hydrogen, halogen, C1˜C10 alkyl group, C2˜C10 alkynyl group, amino group, haloalkyl group and sulfonamide group.
Claims6
A pharmaceutical composition for inhibiting osteoclast precursor growth comprising N-(3-ethynylphenyl)-2-hydroxybenzamide, a pharmaceutically acceptable salt, and a carrier.
Dependencies are inferred from the claim text.